amitriptyline has been researched along with 2019 Novel Coronavirus Disease in 2 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
Excerpt | Relevance | Reference |
---|---|---|
"Headache is one of the most frequently reported symptoms in post-COVID patients." | 5.72 | Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors. ( Arias-Rivas, S; Gago-Veiga, AB; García-Azorín, D; Gonzalez-Martinez, A; Guerrero-Peral, ÁL; Sierra, Á; Silva, L, 2022) |
"Headache is one of the most frequently reported symptoms in post-COVID patients." | 1.72 | Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors. ( Arias-Rivas, S; Gago-Veiga, AB; García-Azorín, D; Gonzalez-Martinez, A; Guerrero-Peral, ÁL; Sierra, Á; Silva, L, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Gonzalez-Martinez, A | 1 |
Guerrero-Peral, ÁL | 1 |
Arias-Rivas, S | 1 |
Silva, L | 1 |
Sierra, Á | 1 |
Gago-Veiga, AB | 1 |
García-Azorín, D | 1 |
Şahin, MF | 1 |
Özcan, R | 1 |
Malak, A | 1 |
Doğan, Ç | 1 |
Yazıcı, CM | 1 |
Özcan, M | 1 |
Akgül, M | 1 |
2 other studies available for amitriptyline and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors.
Topics: Amitriptyline; COVID-19; Female; Headache; Humans; Male; Migraine Disorders; Nausea; Retrospective S | 2022 |
The effect of the pandemic period on Bladder Pain Syndrome patients under amitriptyline treatment.
Topics: Amitriptyline; COVID-19; Cystitis, Interstitial; Female; Humans; Male; Pandemics; Urinary Bladder, O | 2023 |